The estimated Net Worth of John E Sununu is at least $3.69 Milion dollars as of 15 August 2018. John Sununu owns over 72 units of Boston Scientific stock worth over $2,676,059 and over the last 16 years he sold BSX stock worth over $690,909. In addition, he makes $319,979 as Independent Director at Boston Scientific.
Sign up
John Sununu BSX stock SEC Form 4 insiders trading
John has made over 5 trades of the Boston Scientific stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 72 units of BSX stock worth $2,511 on 15 August 2018.
The largest trade he's ever made was selling 29,561 units of Boston Scientific stock on 14 February 2014 worth over $389,318. On average, John trades about 2,214 units every 75 days since 2009. As of 15 August 2018 he still owns at least 32,265 units of Boston Scientific stock.
You can see the complete history of John Sununu stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Sununu biography
Sen. John E. Sununu Jr. serves as Independent Director of the Company. Senator Sununu served as a U.S. Senator from New Hampshire from 2003 to 2009. He was a member of the Committees on Banking, Commerce, Finance and Foreign Relations, and he was appointed the Congressional Representative to the United Nations General Assembly. Before his election to the Senate, Senator Sununu served three terms as a Member of the U.S. House of Representatives from New Hampshire's 1st District from 1996 to 2002. He was Vice Chairman of the Budget Committee and a member of the Appropriations Committee. During his twelve years in Congress, he drafted and helped pass several important pieces of legislation, including the Internet Tax Freedom Act, the Survivors Benefit Act and the New England Wilderness Act. Prior to serving in Congress, Senator Sununu served as Chief Financial Officer for Teletrol Systems, a manufacturer of building control systems. Senator Sununu formerly served as a director of Time Warner Cable Inc.
What is the salary of John Sununu?
As the Independent Director of Boston Scientific, the total compensation of John Sununu at Boston Scientific is $319,979. There are 13 executives at Boston Scientific getting paid more, with Michael Mahoney having the highest compensation of $15,764,100.
How old is John Sununu?
John Sununu is 55, he's been the Independent Director of Boston Scientific since 2009. There are 16 older and 10 younger executives at Boston Scientific. The oldest executive at Boston Scientific Corp. is Yoshiaki Fujimori, 69, who is the Independent Director.
What's John Sununu's mailing address?
John's mailing address filed with the SEC is 300 BOSTON SCIENTIFIC WAY, , MARLBOROUGH, MA, 01752-1234.
Insiders trading at Boston Scientific
Over the last 20 years, insiders at Boston Scientific have traded over $938,841,783 worth of Boston Scientific stock and bought 1,398,972 units worth $16,231,539 . The most active insiders traders include Peter M Nicholas, John E Abele a Michael F Mahoney. On average, Boston Scientific executives and independent directors trade stock every 3 days with the average trade being worth of $4,899,929. The most recent stock trade was executed by Michael F Mahoney on 5 September 2024, trading 162,777 units of BSX stock currently worth $13,212,609.
What does Boston Scientific do?
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
What does Boston Scientific's logo look like?
Complete history of John Sununu stock trades at Boston Scientific
Boston Scientific executives and stock owners
Boston Scientific executives and other stock owners filed with the SEC include:
-
Michael Mahoney,
Chairman of the Board, President, Chief Executive Officer -
Daniel Brennan,
Chief Financial Officer, Executive Vice President -
Joseph Fitzgerald,
Executive Vice President, President, Interventional Cardiology -
Edward Mackey,
Executive Vice President - Operations -
David Pierce,
Executive Vice President and President, MedSurg and President, Endoscopy -
Michael F. Mahoney,
Chairman, Pres & CEO -
Daniel J. Brennan,
Exec. VP & CFO -
Joseph M. Fitzgerald,
Exec. VP & Pres of Interventional Cardiology -
Edward F. Mackey,
Exec. VP of Global Operations -
Jeffrey B. Mirviss,
Exec. VP & Pres of Peripheral Interventions -
Edward Ludwig,
Lead Independent Director -
Charles Dockendorff,
Independent Director -
David Roux,
Independent Director -
John Sununu,
Independent Director -
Donna James,
Independent Director -
Nelda Connors,
Independent Director -
Ellen Zane,
Independent Director -
Stephen MacMillan,
Independent Director -
Yoshiaki Fujimori,
Independent Director -
John Sorenson,
Senior Vice President - Manufacturing and Supply Chain -
Meghan Scanlon,
Senior Vice President and President, Urology and Pelvic Health -
Scott Olson,
Senior Vice President and President, Rhythm Management -
Maulik Nanavaty,
Senior Vice President and President - Neuromodulation -
Wendy Carruthers,
Senior Vice President - Human Resources -
Desiree Ralls-Morrison,
Senior Vice President, General Counsel, Corporate Secretary -
Jodi Eddy,
Senior Vice President, Chief Information Officer -
Eric Thepaut,
Executive Vice President and President - Europe, Middle East and Africa -
Jeffrey Mirviss,
Executive Vice President and President - Peripheral Interventions -
Ian Meredith,
Executive Vice President, Global Chief Medical Officer -
Arthur Butcher,
Executive Vice President and President, Asia Pacific -
Catherine Jennings,
VP of Global Marketing & New Bus. Devel. of Peripheral Interventions -
Vance R. Brown,
Sr. VP, Gen. Counsel & Corp. Sec. -
Susan Vissers Lisa,
VP of Investor Relations -
Jodi Euerle Eddy,
Sr. VP and Chief Information & Digital Officer -
Jonathan R Monson,
VP, Global Controller & Chief Accounting Officer -
Vance R Brown,
SVP, GC and Corp. Secretary -
Timothy A. Pratt,
EVP & General Counsel -
Supratim Bose,
EVP & President, Asia-Pacific -
Michael P. Phalen,
SVP & President, Endoscopy -
Keith D Dawkins,
Sr. VP, Chief Medical Officer -
Kevin J. Ballinger,
EVP & Pres, Interven Cardio -
Cheryl Pegus,
Director -
David S Wichmann,
Director -
Xin Warren Wang,
SVP and Pres, Asia Pacific -
Peter M Nicholas,
Director -
Kristina M Johnson,
Director -
Nicholas J Jr Nicholas,
Director -
Karen Prange,
SVP&Pres, Uro & Women's Health -
Ernest Mario,
Director -
John E Abele,
Director -
Uwe E Reinhardt,
Director -
Katharine T Bartlett,
Director -
Jean Fitterer Lance,
SVP & Chief Compliance Officer -
Kenneth Pucel,
EVP, Operations -
Bruce L Byrnes,
Director -
John Michael Onuscheck,
SVP & Pres-Neuromodulation -
Jeffrey D Capello,
Chief Accounting Officer -
Otha T. Iii Spriggs,
SVP, Human Resources -
William Kucheman,
SVP & Group President -
John Raymond Elliott,
Director -
Lawrence R Neumann,
SVP and Pres, Emerging Markets -
John B. Pedersen,
Pres,Uro & Women's Health -
Brian R Burns,
SVP - Quality -
Ray J Groves,
Director -
Sam R Leno,
CFO & EVP Finance & IS -
Stephen F Moreci,
Sr. VP, Endosurgery -
Marye Anne Fox,
Director -
Fred Colen,
EVP -
John E Pepper,
Director -
James Gilbert,
EVP -
Donovan Paul,
SVP, Corporate Comm -
David W Mc Faul,
Senior VP International -
Ursula M Burns,
Director -
Warren B Rudman,
Director -
William F Jr Mcconnell,
SVP, Administration CRM -
Donald S Baim,
EVP, Chief Med. & Sci. Officer -
Lucia Luce Quinn,
Exec. Vice President-HR -
James R Tobin,
President & CEO -
Paul W Sandman,
EVP and General Counsel -
Paul A Laviolette,
COO -
Nancy Ann Deparle,
Director -
Joel Lawrence Fleishman,
Director -
David C Habiger,
Director -
Jonathan Monson,
SVP, Global Controller and CAO -
Emily Woodworth,
SVP, Global Controller and CAO -
Jessica L Mega,
Director -
Susan E Morano,
Director